标题 |
[求助补充材料] Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
曲妥珠单抗rezetecan(一种HER2导向的抗体—药物偶联物)治疗晚期HER2突变非小细胞肺癌(HORIZON-Lung)患者:一项多中心、单臂研究的2期结果
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |